The deployment aims to improve serialisation efficiency by up to 45% across Annora Pharma’s global export supply chain.
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian pharmaceutical manufacturer, has expanded its collaboration with AltiusHub, deploying the company’s artificial intelligence-native serialisation, track and trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialisation efficiency by up to 45 per cent and strengthen operational visibility across Annora Pharma’s global supply chain. The rollout supports compliance across key export markets including the United States, European Union, GCC, LATAM and ASEAN regions, with the company targeting real-time visibility across 100 per cent of serialised drug products within three months, from packaging line to export dispatch.
The unified platform replaces fragmented legacy systems and supports serialisation, aggregation and multi-market regulatory reporting, integrating with Annora Pharma’s Level 3 packaging infrastructure. The deployment has already resulted in faster serialisation processing and improved packaging floor productivity. Within two years of inception, AltiusHub has enabled serialisation and compliance operations across more than 50 regulated markets, including the United States under the Drug Supply Chain Security Act, the European Union under the Falsified Medicines Directive, Saudi Arabia under the Saudi Food and Drug Authority and the UAE under Tatmeen. Siddharth Reddy, Managing Director of AltiusHub, said the deployment demonstrated that artificial intelligence-native solutions could deliver speed, scalability and control while meeting strict regulatory standards.
Source: AltiusHub and Annora Pharma
